These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3931228)

  • 41. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis.
    Popper H
    Hepatology; 1983; 3(5):758-62. PubMed ID: 6413352
    [No Abstract]   [Full Text] [Related]  

  • 42. [Liver diseases and pregnancy. II: Liver diseases without causal relation to pregnancy--general principles for treatment of patients with liver disease].
    Teichman W; Hauzeur F; During R
    Zentralbl Gynakol; 1985; 107(19):1153-64. PubMed ID: 3934879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 44. [An etiopathogenic and therapeutic update in chronic viral hepatitis in children].
    Moraru E
    Pediatrie (Bucur); 1992; 41(4):13-27. PubMed ID: 1335770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Long-term follow-up of hepatitis B virus infected patients after orthotopic liver transplantation].
    Theilmann L; Arnold JC
    Z Gastroenterol; 1995 Oct; 33(10):626-7. PubMed ID: 7502560
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A; Amitrano L; Riccio E; De Lella A; Canestrini C; de Bellis G; D'Alessandro R; Fiore R; Padulano P
    Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of chronic hepatitis caused by C and non-A, non-B virus (NANB)].
    Trepo C; Causse X
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):343-6. PubMed ID: 2177595
    [No Abstract]   [Full Text] [Related]  

  • 50. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic active hepatitis and related disorders.
    Larcher V
    Clin Gastroenterol; 1986 Jan; 15(1):173-98. PubMed ID: 3082542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
    Simon K; Gładysz A; Zalewska M; Machaj A
    Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immunology of acute and chronic hepatitis.
    Wright R; Rassam S
    Clin Gastroenterol; 1976 May; 5(2):387-417. PubMed ID: 1021327
    [No Abstract]   [Full Text] [Related]  

  • 54. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of hepatitis B.
    Farrell RJ; Weir DG
    Ir Med J; 1995; 88(6):199-201. PubMed ID: 8575916
    [No Abstract]   [Full Text] [Related]  

  • 56. Viral hepatitis and liver transplantation.
    Sharma P; Lok A
    Semin Liver Dis; 2006 Aug; 26(3):285-97. PubMed ID: 16850378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon or corticosteroid: treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases.
    Toda G
    Intern Med; 1997 Apr; 36(4):233-5. PubMed ID: 9187557
    [No Abstract]   [Full Text] [Related]  

  • 58. Functional evaluation in liver disease: immunologic function.
    Mackay IR
    Lab Res Methods Biol Med; 1983; 7():89-101. PubMed ID: 6353116
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of hepatitis and cirrhosis].
    Demling L
    Munch Med Wochenschr; 1966 Nov; 108(44):2231-4. PubMed ID: 6015103
    [No Abstract]   [Full Text] [Related]  

  • 60. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection.
    Féray C; Samuel D; Gigou M; Paradis V; David MF; Lemonnier C; Reynès M; Bismuth H
    Hepatology; 1995 Oct; 22(4 Pt 1):1084-9. PubMed ID: 7557855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.